Celina Dubin

Celina Dubin MD
  • 0,0 (0)
  • SCIENCES
  • TOUS LES JOURS

Celina Dubin recently graduated from medical school with a distinction in research in May 2022. She is currently a resident physician in New York City, where she is training to become a dermatologist.

  1. Celina Dubin MD - A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia

    -2 J

    Celina Dubin MD - A Phase 2a Trial of Brepocitinib for Cicatricial Alopecia

    Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this phase 2a trial, which appeared in the Journal of the American Academy of Dermatology. VIEW FULL DETAILS OF THE PHASE 2A TRIAL IN JAAD HERE: https://www.jaad.org/article/S0190-9622(24)03043-3/fulltext

    2 min
  2. Celina Dubin MD- Vitiligo May Be Associated With an Increased Genetic Risk of Cardiovascular Disease

    3 MAI

    Celina Dubin MD- Vitiligo May Be Associated With an Increased Genetic Risk of Cardiovascular Disease

    This research letter was co-authored by Dr. Celina Dubin, MD, a dermatology resident at the Icahn School of Medicine at Mount Sinai, and was published in the Journal of the American Academy of Dermatology International. SEE THE FULL RANDOMIZATION STUDY IN JAAD INTERNATIONAL HERE: https://www.jaadinternational.org/article/S2666-3287(24)00108-1/fulltext

    2 min
  3. Dr. Celina Dubin, MD-Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

    16 AVR.

    Dr. Celina Dubin, MD-Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients

    Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in the Journal of Allergy and Clinical Immunology. The study examines atopic dermatitis (AD), a common inflammatory skin disease that affects up to 10% of adults worldwide. Read the original paper here: https://www.jacionline.org/article/S0091-6749(20)30039-7/fulltext

    2 min
  4. Dr Celina Dubin-Cross-sectional study of blood biomarkers - moderate/severe alopecia areata patients

    16 AVR.

    Dr Celina Dubin-Cross-sectional study of blood biomarkers - moderate/severe alopecia areata patients

    Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which appeared in the Journal of the American Academy of Dermatology. The goal of the study was to evaluate the blood proteomic signature of alopecia areata (AA) and identify biomarkers associated with increased disease severity. Read the original paper here: https://www.jaad.org/article/S0190-9622(20)30759-3/abstract

    2 min
  5. Celina Dubin MD- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals

    16 AVR.

    Celina Dubin MD- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals

    Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, published in the Journal of Investigative Dermatology (JID). The study evaluated differences in normal skin immune profiles across body locations that are amenable to antigen application and relevant in the context of skin biopsies in clinical trials. Read the original paper here: www.jidonline.org/article/S0022-202X(19)31498-8/fulltext

    2 min
  6. Andres D. Parga, Celina Dubin, Donald Rudikoff Drug-Induced Phototoxicity in Vitiligo The Role of Hydrochlorothiazide in Photosensitivity Dermatitis

    30/12/2025

    Andres D. Parga, Celina Dubin, Donald Rudikoff Drug-Induced Phototoxicity in Vitiligo The Role of Hydrochlorothiazide in Photosensitivity Dermatitis

    Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis. Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in Case Reports in Dermatological Medicine. The study examines the impact of hydrochlorothiazide, a thiazide diuretic commonly used as an antihypertensive agent, in photosensitivity dermatitis, a multifactorial condition characterized by an exaggerated cutaneous response to ultraviolet (UV) radiation, often exacerbated by exogenous agents, particularly photosensitizing medications. This case highlights the need to recognize drug-induced photosensitivity in vitiligo and to better understand how UV vulnerability and photosensitizing medications interact. Read the Wiley Online Library version of the study here: https://onlinelibrary.wiley.com/doi/full/10.1155/crdm/4302190/

    1 min
  7. Celina Dubin, MD- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

    14/12/2025

    Celina Dubin, MD- The use of oral dutasteride, minoxidil, and finasteride for treating endocrine therapy-induced hair loss from breast cancer treatment. A case series study

    Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which was published in the Journal of the American Academy of Dermatology (JAAD). Read the full case study here: https://www.jaadcasereports.org/article/S2352-5126(25)00601-0/fulltext

    1 min
  8. Celina Dubin & Angela Lamb. Hair Regrowth In Endocrine Therapy Alopecia With Dutasteride Treatment.

    22/08/2023

    Celina Dubin & Angela Lamb. Hair Regrowth In Endocrine Therapy Alopecia With Dutasteride Treatment.

    Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer. Celina Dubin MD & Angela Lamb MD Read the full version here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073935/ Or here: https://www.jaadcasereports.org/article/S2352-5126(23)00078-4/fulltext Also appears: https://pubmed.ncbi.nlm.nih.gov/37034026/

    2 min
Tout afficher (26)

À propos

Celina Dubin recently graduated from medical school with a distinction in research in May 2022. She is currently a resident physician in New York City, where she is training to become a dermatologist.

Informations

  • Création
    Celina Dubin MD
  • Années d’activité
    2 k
  • Épisodes
    26
  • Classification
    Tous publics
  • Copyright
    © All rights reserved
  • Site web de l’émission
    Celina Dubin